For the Inventor, By the Inventor

Enter assignee name

Saluggia, Italy

Diasorin S.p.a.

Calculating rank

USPTO Granted Patents = 11

EPO Patents = 14

Trademarks = 4

Forward Citations = 22

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Joshua Soldo (4 out of 5 patents)

Gregory Olson (4 out of 4 patents)

Michael Lutterman (4 out of 4 patents)

4. John Wall (4 out of 8 patents)

5. Michael New (4 out of 4 patents)

6. Fabrizio Bonelli (4 out of 4 patents)

7. Giulia Minnucci (4 out of 4 patents)

8. Hector Floyd Deluca (4 out of 362 patents)

9. Chiara Brambati (2 out of 2 patents)

10. Simone Bocchetta (2 out of 2 patents)

11. Riccardo Mesturini (2 out of 2 patents)

12. Peter D Ludowise (2 out of 23 patents)

13. Francesco Colotta (1 out of 1 patent)

14. Frank Blocki (1 out of 1 patent)

15. Claudia Zierold (1 out of 1 patent)

11 patents: Sort by Forward Citations

1. 11827923 - Method of fluorescent detection of isothermal loop-mediated amplification (LAMP) of a target nucleic acid, oligonucleotides and kits thereof (2023-11-28),

2. 11261257 - Methods for detecting 1,25-dihydroxyvitamin D and related antibodies (2022-03-01),

3. 11149320 - Assays for the detection of SARS-CoV-2 (2021-10-19),

4. 10983136 - Use of 1,25-dihydroxyvitamin D values in ratio with PTH as a prognostic biomarker (2021-04-20),

5. 10982270 - Method of fluorescent detection of isothermal loop-mediated amplification (LAMP) of a target nucleic acid, oligonucleotides and kits thereof (2021-04-20),

6. 10815539 - Assays for the detection of SARS-CoV-2 (2020-10-27),

7. 10501548 - Methods for detecting 1,25-dihydroxyvitamin D and related antibodies (2019-12-10),

8. 10196449 - Method and kit for detecting 1,25-dihydroxyvitamin D and related antibodies (2019-02-05),

9. 9938569 - Compensation for spectral crosstalk in multiplex nucleic acid amplification (2018-04-10),

10. 9725762 - Systems and methods for detecting the presence of a selected volume of material in a sample processing device (2017-08-08),

11. 8329405 - Method for detection of mutant alleles combining real time PCR and REMS-PCR (2012-12-11),

Company Overview

Diasorin S.p.a. is a prominent player in the field of in vitro diagnostics, specializing in the development and manufacturing of diagnostic solutions for various medical applications. The company focuses on immunodiagnostics and molecular diagnostics, providing innovative tools for disease detection and monitoring. With a strong commitment to research and development, Diasorin aims to enhance healthcare outcomes globally, leveraging advanced technologies to support clinical laboratories and healthcare providers in their diagnostic needs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

11 Patents

#4 in Saluggia

#840 in Italy

#51,801 in the World

Saluggia, Italy

Diasorin S.p.a.

Forward Citations = 22

23 inventors:

Joshua Soldo (4 out of 5 patents)

Gregory Olson (4 out of 4 patents)

Michael Lutterman (4 out of 4 patents)

4. John Wall (4 out of 8 patents)

5. Michael New (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Diasorin S.p.a.. Retrieved from https://idiyas.com/company/diasorin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…